publicly available software tools for decision-makers during an emergent epidemic—systematic evaluation of utility and usability
Clicks: 265
ID: 214589
2017
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This
article has not been analysed, so there is no overall score —
reader engagement is measured and shown alongside.
Reader Engagement
Popular Article
30.0
/100
265 views
56 readers
AI Quality Assessment
Not analyzed
Readership in this journal
PopularRanked #49 of 69 articles by views in Communications biology
Most read
Least read
Bar heights use a square-root scale.
Mint this article as an NFT
Not yet mintedCreate a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.
5
SUSD
one-off · no wallet required
Abstract
Epidemics and emerging infectious diseases are becoming an increasing threat to global populations—challenging public health practitioners, decision makers and researchers to plan, prepare, identify and respond to outbreaks in near real-timeframes. The aim of this research is to evaluate the range of public domain and freely available software epidemic modelling tools. Twenty freely utilisable software tools underwent assessment of software usability, utility and key functionalities. Stochastic and agent based tools were found to be highly flexible, adaptable, had high utility and many features, but low usability. Deterministic tools were highly usable with average to good levels of utility.
| Reference Key |
heslop2017epidemicspublicly
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
|---|---|
| Authors | ;David James Heslop;Abrar Ahmad Chughtai;Chau Minh Bui;C. Raina MacIntyre |
| Journal | Communications biology |
| Year | 2017 |
| DOI |
10.1016/j.epidem.2017.04.002
|
| URL | |
| Keywords |
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.